Oxazolone-induced over-expression of focal adhesion kinase in colonic epithelial cells of colitis mouse model

FEBS Letters

Volumn 584, Issue 18, 2010, Pages 3949-3954

  Ma, Yanju ^a   Semba, Shingo ^a   Maemoto, Atsuo ^a   Takeuchi, Masayuki ^a   Kameshita, Isamu ^b   Ishida, Atsuhiko ^c   Kato, Sanae ^a   Katoh, Tsuyoshi ^a   Liu, Yunpeng ^d   Taniguchi, Takanobu ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Crohn's disease; Focal adhesion kinase; Inflammatory bowel disease; Protein tyrosine kinase; Ulcerative colitis

Indexed keywords

FOCAL ADHESION KINASE; OXAZOLONE; FOCAL ADHESION KINASE 1; PTK2 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CELLULAR DISTRIBUTION; COLITIS; COLON MUCOSA; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME LOCALIZATION; EPITHELIUM CELL; GENE OVEREXPRESSION; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CHEMICALLY INDUCED; COLON; DISEASE MODEL; DRUG EFFECTS; ENZYMOLOGY; INTESTINE MUCOSA; PATHOLOGY;

ANIMALS; COLITIS; COLON; DISEASE MODELS, ANIMAL; FOCAL ADHESION KINASE 1; INTESTINAL MUCOSA; MALE; MICE; MICE, INBRED BALB C; OXAZOLONE;

MUS;

EID: 77956901458     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.07.054     Document Type: Article

References (42)

1. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 2003, 3:521-533.
2. Fujino S., Andoh A., Bamba S., Ogawa A., Hata K., Araki Y., Bamba T., Fujiyama Y. Increased expression of interleukin 17 in inflammatory bowel disease. Gut 2003, 52:65-70.
3. Kobayashi T., Okamoto S., Hisamatsu T., Kamada N., Chinen H., Saito R., Kitazume M., Nakazawa A., Sugita A., Koganei K., Isobe K., Hibi T. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease. Gut 2008, 57:1682-1689.
4. Fuss I., Heller F., Boirivant M., Leon F., Yoshida M., Fichtner-Feigl S., Yang Z., Exley M., Kitani A., Blumberg R., Mannon P., Strober W. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J. Clin. Invest. 2004, 113:1490-1497.
5. Abraham C., Cho J. Inflammatory bowel disease. N. Engl. J. Med. 2009, 361:2066-2078.
6. Podolsky D. Inflammatory bowel disease. N. Engl. J. Med. 2002, 347:417-429.
7. Bonen D., Ogura Y., Nicolae D., Inohara N., Saab L., Tanabe T., Chen F., Foster S., Duerr R., Brant S., Cho J., Nunez G. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 2003, 124:140-146.
8. Lorenz R., Newberry R. Isolated lymphoid follicles can function as sites for induction of mucosal immune responses. Ann. N. Y. Acad. Sci. 2004, 1029:44-57.
9. Nenci A., Becker C., Wullaert A., Gareus R., van Loo G., Danese S., Huth M., Nikolaev A., Neufert C., Madison B., Gumucio D., Neurath M., Pasparakis M. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007, 446:557-561.
10. Macdonald T., Monteleone G. Immunity, inflammation, and allergy in the gut. Science 2005, 307:1920-1925.
11. Abreu M., Fukata M., Arditi M. TLR signaling in the gut in health and disease. J. Immunol. 2005, 174:4453-4460.
12. Fellermann K., Stange D., Schaeffeler E., Schmalzl H., Wehkamp J., Bevins C., Reinisch W., Teml A., Schwab M., Lichter P., Radlwimmer B., Stange E. A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am. J. Hum. Genet. 2006, 79:439-448.
13. Cario E., Podolsky D. Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 2000, 68:7010-7017.
14. Ortega-Cava C., Ishihara S., Rumi M., Aziz M., Kazumori H., Yuki T., Mishima Y., Moriyama I., Kadota C., Oshima N., Amano Y., Kadowaki Y., Ishimura N., Kinoshita Y. Epithelial toll-like receptor 5 is constitutively localized in the mouse cecum and exhibits distinctive down-regulation during experimental colitis. Clin. Vaccine Immunol. 2006, 13:132-138.
15. Sugiyama Y., Sueyoshi N., Shigeri Y., Tatsu Y., Yumoto N., Ishida A., Taniguchi T., Kameshita I. Generation and application of a monoclonal antibody that detects a wide variety of protein tyrosine kinases. Anal. Biochem. 2005, 347:112-120.
16. Kojima R., Kuroda S., Ohkishi T., Nakamaru K., Hatakeyama S. Oxazolone-induced colitis in BALB/C mice. A new method to evaluate the efficacy of therapeutic agents for ulcerative colitis. J. Pharmacol. Sci. 2004, 96:307-313.
17. Sykes A., Bhogal R., Brampton C., Chander C., Whelan C., Parsons M., Bird J. The effect of an inhibitor of matrix metalloproteinases on colonic inflammation in a trinitrobenzenesulphonic acid rat model of inflammatory bowel disease. Aliment. Pharmacol. Ther. 1999, 13:1535-1542.
18. Komano H., Fujiura Y., Kawaguchi M., Matsumoto S., Hashimoto Y., Obana S., Mombaerts P., Tonegawa S., Yamamoto H., Itohara S. Homeostatic regulation of intestinal epithelia by intraepithelial gamma delta T cells. Proc. Natl. Acad. Sci. USA 1995, 92:6147-6151.
19. Kashiwamura M., Kurohane K., Tanikawa T., Deguchi A., Miyamoto D., Imai Y. Shiga toxin kills epithelial cells isolated from distal but not proximal part of mouse colon. Biol. Pharm. Bull. 2009, 32:1614-1617.
20. Boirivant M., Fuss I., Chu A., Strober W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 1998, 188:1929-1939.
21. Wirtz S., Neufert C., Weigmann B., Neurath M. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2007, 2:541-546.
22. Wilkins M., Gasteiger E., Bairoch A., Sanchez J., Williams K., Appel R., Hochstrasser D. Protein identification and analysis tools in the ExPASy server. Methods Mol. Biol. 1999, 112:531-552.
23. Szabo I., Pai R., Jones M., Ehring G., Kawanaka H., Tarnawski A. Indomethacin delays gastric restitution: association with the inhibition of focal adhesion kinase and tensin phosphorylation and reduced actin stress fibers. Exp. Biol. Med. (Maywood) 2002, 227:412-424.
24. Tarnawski A., Szabo I., Husain S., Soreghan B. Regeneration of gastric mucosa during ulcer healing is triggered by growth factors and signal transduction pathways. J. Physiol. Paris 2001, 95:337-344.
25. Walsh M., Ampasala D., Hatfield J., Vander Heide R., Suer S., Rishi A., Basson M. Transforming growth factor-beta stimulates intestinal epithelial focal adhesion kinase synthesis via Smad- and p38-dependent mechanisms. Am. J. Pathol. 2008, 173:385-399.
26. Heller F., Fuss I., Nieuwenhuis E., Blumberg R., Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002, 17:629-638.
27. Sakanoue Y., Hatada T., Horai T., Okamoto T., Kusunoki M., Utsunomiya J. Increased protein tyrosine kinase activity of the colonic mucosa in ulcerative colitis. Scand. J. Gastroenterol. 1992, 27:686-690.
28. Kitamura S., Kondo S., Shinomura Y., Isozaki K., Kanayama S., Higashimoto Y., Minami T., Kiyohara T., Yasunaga Y., Ishikawa H., Ohtani T., Ishiguro S., Matsuzawa Y. Expression of hepatocyte growth factor and c-met in ulcerative colitis. Inflamm. Res. 2000, 49:320-324.
29. Sipos F., Molnar B., Zagoni T., Berczi L., Tulassay Z. Growth in epithelial cell proliferation and apoptosis correlates specifically to the inflammation activity of inflammatory bowel diseases: ulcerative colitis shows specific p53- and EGFR expression alterations. Dis. Colon Rectum 2005, 48:775-786.
30. Trzcinski R., Bry M., Krajewska W., Kulig M., Dzyiki A. ErbB-1 expression in experimental model of inflammatory bowel disease in rats. Acta Chir. Iugosl. 2004, 51:85-89.
31. Yoshizaki A., Nakayama T., Naito S., Sekine I. Expression patterns of angiopoietin-1, -2, and tie-2 receptor in ulcerative colitis support involvement of the angiopoietin/tie pathway in the progression of ulcerative colitis. Dig. Dis. Sci. 2009, 54:2094-2099.
32. Sipos F., Galamb O., Herszenyi L., Molnar B., Solymosi N., Zagoni T., Berczi L., Tulassay Z. Elevated insulin-like growth factor 1 receptor, hepatocyte growth factor receptor and telomerase protein expression in mild ulcerative colitis. Scand. J. Gastroenterol. 2008, 43:289-298.
33. Hirayama I., Ide M., Asao T., Kuwano H. Receptor protein tyrosine kinase Ron is highly expressed in colorectal mucosa of ulcerative colitis patients. Hepatogastroenterology 2007, 54:1672-1675.
34. van Nimwegen M., van de Water B. Focal adhesion kinase: a potential target in cancer therapy. Biochem. Pharmacol. 2007, 73:597-609.
35. Mon N., Hasegawa H., Thant A., Huang P., Tanimura Y., Senga T., Hamaguchi M. A role for focal adhesion kinase signaling in tumor necrosis factor-alpha-dependent matrix metalloproteinase-9 production in a cholangiocarcinoma cell line, CCKS1. Cancer Res. 2006, 66:6778-6784.
36. Golubovskaya V., Kaur A., Cance W. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. Biochim. Biophys. Acta 2004, 1678:111-125.
37. Hollenbach E., Neumann M., Vieth M., Roessner A., Malfertheiner P., Naumann M. Inhibition of p38 MAP kinase- and RICK/NF-kappaB-signaling suppresses inflammatory bowel disease. FASEB J. 2004, 18:1550-1552.
38. Owen J.D., Ruest P.J., Fry D.W., Hanks S.K. Induced focal adhesion kinase (FAK) expression in FAK-null cells enhances cell spreading and migration requiring both auto- and activation loop phosphorylation sites and inhibits adhesion-dependent tyrosine phosphorylation of Pyk2. Mol. Cell. Biol. 1999, 19:4806-4818.
39. Yu C.F., Sanders M.A., Basson M.D. Human caco-2 motility redistributes FAK and paxillin and activates p38 MAPK in a matrix-dependent manner. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 278:G952-966.
40. Vandenabeele P., Declercq W., Beyaert R., Fiers W. Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 1995, 5:392-399.
41. Corredor J., Yan F., Shen C., Tong W., John S., Wilson G., Whitehead R., Polk D. Tumor necrosis factor regulates intestinal epithelial cell migration by receptor-dependent mechanisms. Am. J. Physiol. Cell Physiol. 2003, 284:C953-961.
42. Hibi T., Ogata H., Sakuraba A. Animal models of inflammatory bowel disease. J. Gastroenterol. 2002, 37:409-417.